These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


252 related items for PubMed ID: 4948349

  • 1. Levodopa in Parkinsonism.
    Weiss JL, Chase TN.
    Drugs; 1971; 2(4):257-61. PubMed ID: 4948349
    [No Abstract] [Full Text] [Related]

  • 2. [10 years of L-DOPA therapy of Parkinson's syndrome].
    Birkmayer W.
    Wien Klin Wochenschr; 1971 Apr 02; 83(13):221-7. PubMed ID: 4254333
    [No Abstract] [Full Text] [Related]

  • 3. L-Dopa in the treatment of parkinsonism.
    Calne DB.
    Clin Pharmacol Ther; 1970 Apr 02; 11(6):789-801. PubMed ID: 4921292
    [No Abstract] [Full Text] [Related]

  • 4. [Modern treatment of parkinsonism].
    Birkmayer W, Neumayer E.
    Z Neurol; 1972 Apr 02; 202(4):257-80. PubMed ID: 4117647
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of parkinsonism with levodopa.
    Yahr MD, Duvoisin RC, Schear MJ, Barrett RE, Hoehn MM.
    Arch Neurol; 1969 Oct 02; 21(4):343-54. PubMed ID: 5820999
    [No Abstract] [Full Text] [Related]

  • 6. Therapeutic uses and side effects of L-dopa.
    Boshes B.
    Adv Intern Med; 1972 Oct 02; 18():219-49. PubMed ID: 4576081
    [No Abstract] [Full Text] [Related]

  • 7. L-Dopa treatment in Parkinson's Disease.
    Rinne UK, Sonninen V, Siirtola T.
    Eur Neurol; 1970 Oct 02; 4(6):348-69. PubMed ID: 4932969
    [No Abstract] [Full Text] [Related]

  • 8. Levodopa and related drugs.
    Med Lett Drugs Ther; 1973 Mar 02; 15(5):21-3. PubMed ID: 4697470
    [No Abstract] [Full Text] [Related]

  • 9. [The therapeutic effect of L-dopa].
    Groneberg P, Struppler A.
    Naturwissenschaften; 1972 Nov 02; 59(11):492-6. PubMed ID: 4657650
    [No Abstract] [Full Text] [Related]

  • 10. The treatment of parkinsonism with levodopa.
    Sutcliffe RL.
    Gerontol Clin (Basel); 1974 Nov 02; 16(1):151-6. PubMed ID: 4855131
    [No Abstract] [Full Text] [Related]

  • 11. Sustained levodopa therapy in parkinsonism.
    Hunter KR, Shaw KM, Laurence DR, Stern GM.
    Lancet; 1973 Oct 27; 2(7835):929-31. PubMed ID: 4126558
    [No Abstract] [Full Text] [Related]

  • 12. [Biochemical bases for the treatment of Parkinson's syndrome with L-dopa].
    Pletscher A, Bartholini G, Gey KF, Jenni A.
    Schweiz Med Wochenschr; 1970 May 09; 100(19):797-804. PubMed ID: 4924275
    [No Abstract] [Full Text] [Related]

  • 13. Parkinsonism, levodopa, and anesthesia.
    Ngai SH.
    Anesthesiology; 1972 Sep 09; 37(3):344-51. PubMed ID: 4559395
    [No Abstract] [Full Text] [Related]

  • 14. L-DOPA in Parkinson's disease. Results of a co-operative study in the Montreal area.
    Mars H, Libman I, Schwartz AM, Gillo-Joffroy L, Barbeau A.
    Can Psychiatr Assoc J; 1972 Apr 09; 17(2):123-31. PubMed ID: 5036506
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of Parkinsonism with a combination of levodopa and the decarboxylase inhibitor and RO 46-4602 (a comparison with levodopa treatment alone).
    Dupont E, Hansen E, Melsens S, Parkenberg H, Holm P.
    Acta Neurol Scand Suppl; 1972 Apr 09; 51():115-7. PubMed ID: 4514334
    [No Abstract] [Full Text] [Related]

  • 16. Levodopa in treating Parkinsonism.
    O'Doherty DS.
    Am Fam Physician; 1971 Nov 09; 4(5):95-9. PubMed ID: 5117507
    [No Abstract] [Full Text] [Related]

  • 17. [Indications and results of monoamine treatment in parkinsonian syndromes].
    Boudin G, Pépin B, Guillard A, Fabiani JM, Haguenau M.
    Rev Neurol (Paris); 1972 Jul 09; 127(1):79-97. PubMed ID: 4520464
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy of and possible differences in tolerance to L-dopa tablets with different rates of release of the active substance.
    Völler GW, Muschard F.
    Acta Neurol Scand; 1974 Jul 09; 50(3):391-3. PubMed ID: 4525037
    [No Abstract] [Full Text] [Related]

  • 19. Recent advances in the treatment of Parkinsonism with drugs.
    Rinne UK.
    Acta Neurol Scand Suppl; 1972 Jul 09; 51():59-103. PubMed ID: 4576076
    [No Abstract] [Full Text] [Related]

  • 20. Theoretical implications of the use of L-dopa in parkinsonism. A review.
    Klawans H, Ilahi MM, Shenker D.
    Acta Neurol Scand; 1970 Jul 09; 46(4):409-41. PubMed ID: 4323341
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.